Diagnosing and managing Long COVID is a complicated business

Embargoed until: Publicly released: 2022-11-04 02:00

International

CC-0

A US study of health records of 200 randomly selected veterans who'd had COVID-19 and had at least one symptom suggestive of Long COVID found it is often unclear whether symptoms are the result of having Long COVID, or of some other underlying health problem. They say there are no known tests or detectable markers for Long COVID, which can lead to ongoing monitoring, COVID-19 testing and medical referrals for patients thought to have the condition. They also identified problems with post-COVID-19 care in the US healthcare system - care processes were often siloed from other care and could be burdensome to patients, they say.

Media release

From: JAMA

Complexity, Challenges of the Clinical Diagnosis, Management of Long COVID

About The Study: This analysis of the health records of a random national sample of 200 veterans who had experienced SARS-CoV-2 infection and who had at least one diagnostic code for long COVID highlights the complexity of diagnosing long COVID in clinical settings and the challenges of caring for patients who have or are suspected of having this condition.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: VA Puget Sound Health Care System, USA

Funder: The study was supported using data from the VA COVID-19 Shared Data Resource and the resources and facilities of the VA Informatics and Computing Infrastructure (VA HSR&D grant No. RES 13-457) and by VA HSR&D grant No. IIR-278 (Drs , Maciejewski, Boyko, Bohnert, and Ioannou), IIR-279 (Drs O’Hare, Iwashyna, Viglianti, Bowling, and Hynes), and SRCS 21-136 (Dr Hynes).

Media Contact/s

Contact details are only visible to registered journalists.